Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28581142 | 0.78 | USP2 (0.32) | USP2NPSR1 | |
| SCHEMBL1783918 | 0.78 | USP2 (0.36) | USP2NPSR1 | |
| SCHEMBL2986881 | 0.78 | USP2 (0.36) | USP2NPSR1 | |
| SCHEMBL1783922 | 0.78 | USP2 (0.36) | USP2NPSR1 | |
| SCHEMBL8804297 | 0.76 | TDP1 (0.39) | USP2NPSR1 | |
| SCHEMBL8804291 | 0.76 | TDP1 (0.39) | USP2NPSR1 | |
| SCHEMBL8462040 | 0.76 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL7784007 | 0.76 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL8804438 | 0.76 | TDP1 (0.39) | USP2NPSR1 | |
| SCHEMBL28581143 | 0.73 | OPRM1 (0.32) | USP2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3880648-B1 | ACETATE COMPOUND USEFUL AS ODORANT | GIVAUDAN SA (CH) | 2024-08-28 | — | — | EP | disclosed |
| US-12012570-B2 | Acetate compounds useful as odorants | GIVAUDAN SA (CH) | 2024-06-18 | — | — | US | disclosed |
| US-20220119733-A1 | ACETATE COMPOUNDS USEFUL AS ODORANTS | GIVAUDAN SA (CH) | 2022-04-21 | — | — | US | disclosed |
| EP-3880648-A1 | ACETATE COMPOUNDS USEFUL AS ODORANTS | Givaudan SA (CH) | 2021-09-22 | — | — | EP | disclosed |
| WO-2020098927-A1 | ACETATE COMPOUNDS USEFUL AS ODORANTS | GIVAUDAN SA (CH) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12012570-B2 | Acetate compounds useful as odorants | OR10J3, OR51E2, TRPA1 | F10 1890/4885USP2 3490/4885NPSR1 550/4885 |
| US-20220119733-A1 | ACETATE COMPOUNDS USEFUL AS ODORANTS | OR10J3, OR51E2, TRPA1 | F10 1890/4885USP2 3490/4885NPSR1 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.